pfizer glp-1 news scraps daily weight loss pill danuglipron after a liver injury ACQUISITIONS & MERGERS NEWS: Pfizer...

l , Schematic highlighting the nucleus accumbens

Appetite 172 , 105965 (2022)

Geniposide and Its Iridoid Analogs Exhibit Antinociception by Acting at the Spinal GLP-1 Receptors

But it wasnt until semaglutide hit the market (first as Ozempic [archived link] in 2017 followed by Wegovy [archived link]) in 2021) that GLP-1 RAs captured the worlds attention

Preclinical studies have revealed their ability to reduce neuroinflammation, reduce tau phosphorylation, reduce amyloid deposition, and improve memory formation, all of which are implicated in the progression of neurodegeneration

GLP-1 agonist to treat obesity and prevent cardiovascular disease: What have we achieved so far